Dugie Standeford

Dugie Standeford

New US Law Requires Reporting Of Biologic, Biosimilar “Pay-for-Delay” Pacts

The Patient Right to Know Drug Prices Act became effective in the United States on 10 October. Among other things, it extends to biologic and biosimilar products a 2003 law requiring drug manufacturers to notify US antitrust authorities of patent settlement agreements. The idea is to cut down on so-called “pay-for delay” tactics which can slow the introduction of cheaper medicines into the market.

Microsoft Joins Open Invention Network In A “Nice Validation” Of Open Source Movement

Tech giant Microsoft’s 10 October announcement that it will participate in the Open Invention Network is a “nice validation” of the organisation and a pragmatic acknowledgement that the open source software community is interdependent, CEO Keith Bergelt said in an 11 October interview. Microsoft said its decision to join reflects its changing views on patent practice.

European Parliament Approves Negotiating Stance On Copyright Reform

European Union lawmakers today approved by a 438-226 margin a measure updating EU copyright law and voted to begin negotiations with the European Commission (EC) and Council. The vote followed parliamentary rejection in June of plans to launch an immediate “trilogue” with the EC and Council based on text as approved by the lead Legal Affairs Committee (JURI), instead sending the measure for full debate at the September plenary held today.

EU Copyright Reform Proposal Clears Lead Legislative Committee, To Cheers And Jeers

The European Parliament Legal Affairs Committee (JURI) adopted its report on the European Commission-proposed copyright in the digital single market directive yesterday. The vote, by the lead committee vetting the proposal, sparked a continuation of the acrimonious debate that has raged for many months over several controversial provisions: The creation of a new right for online publishers and a requirement that Internet platforms monitor users’ uploads for copyright infringements. The narrow majority that approved the report by German Member of the European Parliament (MEP) Axel Voss, of the European People’s Party, “suggests that the struggle is still long,” telecom consultant Innocenzo Genna blogged.

EPO Staff, Users List Priorities For Incoming President

As the European Patent Office (EPO) prepares to welcome a new president, staff members and patent practitioners are setting out their priorities and suggestions for the newcomer, António Campinos. Topping the list for patent examiners is ending the contentious relationship between management and employees. Patent attorneys and litigators, meanwhile, want to see more attention paid to creating a fair balance between the speed of patent grants and patent quality.